Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kimihiro Shimizu"'
Autor:
Yoshiaki Takase, Kengo Usui, Kimihiro Shimizu, Yasumasa Kimura, Tatsuo Ichihara, Takahiro Ohkawa, Jun Atsumi, Yasuaki Enokida, Seshiru Nakazawa, Kai Obayashi, Yoichi Ohtaki, Toshiteru Nagashima, Yasumasa Mitani, Izumi Takeyoshi
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171225 (2017)
Somatic mutation in human epidermal growth factor receptor-related 2 gene (HER2) is one of the driver mutations in lung cancer. HER2 mutations are found in about 2% of lung adenocarcinomas (ADCs). Previous reports have been based mainly on diagnostic
Externí odkaz:
https://doaj.org/article/6569c880dde0404f931ab6ee0fa2ad93
Autor:
Yasuaki Enokida, Kimihiro Shimizu, Jun Atsumi, Alexander Lezhava, Yuki Tanaka, Yasumasa Kimura, Takahiro Soma, Takeshi Hanami, Yuki Kawai, Kengo Usui, Yasuko Okano, Seiichi Kakegawa, Hiroomi Ogawa, Yohei Miyamae, Yohei Miyagi, Haruhiko Nakayama, Toshihisa Ishikawa, Yoshihide Hayashizaki, Izumi Takeyoshi
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e60151 (2013)
Genetic polymorphisms in the human MDM2 gene are suggested to be a tumor susceptibility marker and a prognostic factor for cancer. It has been reported that a single nucleotide polymorphism (SNP) c.309T>G in the MDM2 gene attenuates the tumor suppres
Externí odkaz:
https://doaj.org/article/27ebff1e61fa4d8da1d9b9437c54c7db
Autor:
Yasuaki Enokida, Yasumasa Mitani, Izumi Takeyoshi, Takahiro Ohkawa, Yoshiaki Takase, Kimihiro Shimizu, Yoichi Ohtaki, Kai Obayashi, Jun Atsumi, Kengo Usui, Yasumasa Kimura, Seshiru Nakazawa, Toshiteru Nagashima, Tatsuo Ichihara
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171225 (2017)
PLoS ONE
PLoS ONE
Somatic mutation in human epidermal growth factor receptor-related 2 gene (HER2) is one of the driver mutations in lung cancer. HER2 mutations are found in about 2% of lung adenocarcinomas (ADCs). Previous reports have been based mainly on diagnostic
Autor:
Kengo Usui, Alexander Lezhava, Jun Atsumi, Yohei Miyamae, Yuki Kawai, Izumi Takeyoshi, Takeshi Hanami, Haruhiko Nakayama, Yohei Miyagi, Kimihiro Shimizu, Toshihisa Ishikawa, Yuki Tanaka, Yasuaki Enokida, Seiichi Kakegawa, Yoshihide Hayashizaki, Yasuko Okano, Yasumasa Kimura, Hiroomi Ogawa, Takahiro Soma
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 4, p e60151 (2013)
PLoS ONE, Vol 8, Iss 4, p e60151 (2013)
Background Genetic polymorphisms in the human MDM2 gene are suggested to be a tumor susceptibility marker and a prognostic factor for cancer. It has been reported that a single nucleotide polymorphism (SNP) c.309T>G in the MDM2 gene attenuates the tu